Health and Fitness

Not intended for U.S. and UK Media Berlin, August 8, 2022 – Bayer announced today the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for the oral androgen receptor inhibitor (ARi) darolutamide in combination with docetaxel for the treatment of patients with metastatic hormone-sensitive prostate cancer (mHSPC). The approval …

U.S. FDA approves additional indication of darolutamide in combination with docetaxel for the treatment of metastatic hormone-sensitive prostate cancer (mHSPC) Read More »

Leverkusen, August 4, 2022 – The Bayer Group achieved substantial growth in the second quarter of 2022. “We delivered strong operational performance. In terms of sales, we posted significant gains at Crop Science and strong growth at Consumer Health, as well as a slight increase at Pharmaceuticals, too. And with EBITDA before special items, we …

Bayer: Strong growth, outlook raised Read More »

Berlin, July 14, 2022 – Bayer and Grünenthal have entered into a definitive agreement regarding the sale of Bayer’s men’s health product Nebido™ (testosterone undecanoate), for a purchase price totaling up to 500 million Euro. Nebido for the treatment of male hypogonadism (testosterone deficiency) is available in over 80 countries since 2004. In 2021, the …

Bayer to sell men’s health product Nebido™ to Grünenthal Read More »

Berlin / Boston, June 29, 2022 – Bayer AG announced today the opening of its new Research and Innovation Center at Kendall Square in Boston-Cambridge, Massachusetts (U.S.A.), expanding further the company’s footprint into one of the world’s most innovative pharmaceutical research and development locations. Representing a total $140M USD investment into the area, Bayer’s 62,100-square-foot …

Bayer opens new Research & Innovation Center in Boston-Cambridge demonstrating its commitment to precision oncology Read More »

The Lincoln Lawyer is officially back for Season 2. A new season brings new cases for defense attorney Mickey Haller and, of course, a new cast of characters for him to deal with. Netflix’s The Lincoln Lawyer follows defense attorney Mickey Haller (played by Manuel Garcia-Rulfo), who works in Los Angeles and is known for …

Here’s Who Plays Andy Freeman on Netflix’s The Lincoln Lawyer Season 2 Read More »

Leverkusen, October 5, 2022 – Bayer has completed the sale of its Environmental Science Professional business to the international private equity firm Cinven, after the two companies had entered into a corresponding agreement in March. The conditions for closing the transaction – including the receipt of regulatory approval – have now been met. The purchase …

Bayer completes sale of its Environmental Science Professional business to Cinven Read More »

Not intended for U.S. and UK Media Berlin, September 8, 2022 – Bayer AG today announced the primary endpoint was met in two pivotal trials investigating aflibercept 8 mg with 12- and 16-week dosing regimens in patients with neovascular (wet) age-related macular degeneration (nAMD) and diabetic macular edema (DME) at week 48. The Phase III …

Aflibercept 8 mg first to achieve extended injection intervals of 16 weeks in up to 89% of patients Read More »

Leverkusen, September 1, 2022 – Cologne Local Court (Amtsgericht Köln) has appointed Kimberly Mathisen (50) to the Supervisory Board of Bayer AG. Mathisen, who holds dual U.S. and Norwegian citizenship, succeeds Professor Fei-Fei Li (45), who stepped down from the Board at the end of August due to personal medical reasons. Li, a leading expert …

Kimberly Mathisen appointed to the Supervisory Board of Bayer AG Read More »

Not intended for U.S. and UK Media Berlin, August 28, 2022 – Bayer announced today the start of a Phase III clinical development program “OCEANIC” to investigate the efficacy and safety of asundexian, an oral Factor XIa (FXIa) inhibitor, as a potential new treatment in patients with atrial fibrillation and in patients with a non-cardioembolic …

Bayer initiates landmark Phase III study program to investigate oral FXIa inhibitor asundexian Read More »

Leverkusen, August 18, 2022 – Bayer supports the humanitarian non-profit organization “Fondation suisse de déminage” (FSD) in their mission to demine land that was contaminated by mines and unexploded devices since the onset of the war in Ukraine. A donation of 825,000 euros will be dedicated to purchasing a large-size mechanical mine clearance machine. The machine …

Bayer supports demining in Ukraine with donation to non-profit “Fondation suisse de déminage” Read More »